Kai Rothaus
Overview
Explore the profile of Kai Rothaus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gunnemann M, Ziegler M, Book M, Gunnemann F, Rothaus K, Spital G, et al.
Klin Monbl Augenheilkd
. 2024 Jan;
241(12):1335-1340.
PMID: 38181813
Background: Anti-VEGF therapy is the standard treatment for exudative neovascular age-related macular degeneration (nAMD) caused by the development of macular neovascularisation (MNV) with associated fluid exudation. The therapeutic strategies (T&E...
2.
Glandorf K, Rothaus K, Baquet-Walscheid K, Heinz C, Heiligenhaus A
Ocul Immunol Inflamm
. 2023 Mar;
32(5):636-641.
PMID: 36898006
Purpose: Patients with juvenile idiopathic arthritis (JIA) associated uveitis (JIAU) are at risk for secondary glaucoma, frequently requiring surgical management. We compared the success rates for trabeculectomy (TE) and Ahmed...
3.
Philippi D, Rothaus K, Castelli M
Sci Rep
. 2023 Jan;
13(1):517.
PMID: 36627357
Neovascular age-related macular degeneration (nAMD) is one of the major causes of irreversible blindness and is characterized by accumulations of different lesions inside the retina. AMD biomarkers enable experts to...
4.
Faatz H, Rothaus K, Ziegler M, Book M, Spital G, Lange C, et al.
Diagnostics (Basel)
. 2022 Nov;
12(11).
PMID: 36428867
Introduction: Anti-VEGF therapy is an effective option for improving and stabilizing the vision in neovascular age-related macular degeneration (nAMD). However, the response to treatment is markedly heterogeneous. The aim of...
5.
Rothaus K, Kintzinger K, Heimes-Bussmann B, Faatz H, Lommatzsch A
Klin Monbl Augenheilkd
. 2022 Aug;
241(7):837-844.
PMID: 35926516
Background: Under the influence of the COVID 19 pandemic and the lockdown in Germany, there were significantly fewer consultations in almost all medical disciplines. Especially given the need for consistent...
6.
Lommatzsch C, Rothaus K, Schopmeyer L, Feldmann M, Bauer D, Grisanti S, et al.
Sci Rep
. 2022 Jul;
12(1):11801.
PMID: 35821224
The purpose of this study was to ascertain whether a correlation exists between glaucoma-associated alteration of ocular vascular haemodynamics and endothelin-1 (ET-1) levels exist. Eyes of patients with cataract (n ...
7.
Faatz H, Rothaus K, Ziegler M, Book M, Heimes-Bussmann B, Pauleikhoff D, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327496
Background: The clinical appearance of macular neovascularization (MNV) in age-related macular degeneration (nAMD) varies widely, but so far, this has had no relevance in terms of therapeutic approaches or prognosis....
8.
Kuhlmann J, Rothaus K, Jiang X, Heimes-Bussmann B, Faatz H, Book M, et al.
Transl Vis Sci Technol
. 2022 Feb;
11(2):21.
PMID: 35147662
Purpose: The purpose of this study is to describe and quantify the nonpathological axial stretching in the retinal vascular plexus in three-dimensional (3D) optical coherence tomography angiography (OCTA) images. Methods:...
9.
Gutfleisch M, Ester O, Aydin S, Quassowski M, Spital G, Lommatzsch A, et al.
Graefes Arch Clin Exp Ophthalmol
. 2022 Jan;
260(7):2217-2230.
PMID: 35064365
Purpose: Anti-vascular endothelial growth factor (Anti-VEGF) therapy is currently seen as the standard for treatment of neovascular AMD (nAMD). However, while treatments are highly effective, decisions for initial treatment and...
10.
Baquet-Walscheid K, Rothaus K, Niewerth M, Klotsche J, Minden K, Heiligenhaus A
J Rheumatol
. 2022 Jan;
49(7):719-724.
PMID: 35034000
Objective: Data on uveitis in juvenile psoriatic arthritis (JPsA), a category of juvenile idiopathic arthritis (JIA), are scarce. We describe prevalence and risk factors for JPsA-associated uveitis (JPsA-U). Methods: Cross-sectional...